Skip to ContentSkip to MenuSkip to Footer
Back to Press Releases
Thursday, May 15, 2025Product Launch

TheraNovex Announces Launch of StudyLoop.io Platform

Revolutionary AI-powered platform reduces clinical trial recruitment timelines by up to 65%

Birmingham, AL - May 15, 2025 - TheraNovex, a leading clinical research technology company, today announced the official launch of StudyLoop.io, a revolutionary AI-powered platform designed to transform clinical trial recruitment and patient engagement across the healthcare industry.

The StudyLoop.io platform addresses one of the most significant challenges facing clinical research today: inefficient patient recruitment and retention.

Game-Changing Technology for Clinical Research

StudyLoop.io leverages advanced artificial intelligence and machine learning algorithms to streamline the entire patient recruitment process. The platform's precision matching technology analyzes thousands of data points to identify and connect the most suitable participants with appropriate clinical trials, reducing recruitment timelines by up to 65%.

Stay Updated

Join our waitlist to receive the latest news and updates from TheraNovex.